The leading hypothesis of the past three decades, known as the “Amyloid Cascade” hypothesis, suggests that deposition of large quantities of Aβ peptide initiates a “cascade” of other AD-linked pathophysiological symptoms, including the production of tau-containing neurofibrillary tangles [27] and eventual degeneration of neurons [28]. This evidence concerns the gene MAPT and Alzheimer disease.